ARCHIVES

Iniparib Doesn’t Meet Survival, PFS Endpoints In Phase III Trial in Triple-Negative Breast Cancer

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

NIH Advisors Suggest Revamping Grant Application Review

June 14, 1996

CMX001 Reduces Adenovirus Progression and Viremia

August 30, 2013

In Brief: Peter Jones Is Interim director of USC’s Norris; NIAMS Funds Skin Disease Corse At Yale, Texas

January 1, 1993

Elderly and Younger Patients Have Similar Outcomes Following Radioembolization

July 26, 2013

Cancer Congress Scientific Program To Update Basic, Clinical Science

April 2, 1982

National Cancer Policy Board a Successful Experiment, NCI Says; Funding Extended

May 19, 2000